Plexus Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Plexus stock.
View analyst ratings for Plexus or view top-rated stocks.

3 brokerages have issued 12 month target prices for Plexus' shares. Their PLXS stock forecasts range from $90.00 to $110.00. On average, they anticipate Plexus' stock price to reach $100.00 in the next year. This suggests a possible upside of 28.8% from the stock's current price.
View analysts' price targets for Plexus or view top-rated stocks among Wall Street analysts.

Plexus' stock was trading at $95.89 at the beginning of 2022. Since then, PLXS shares have decreased by 19.1% and is now trading at $77.62.
View the best growth stocks for 2022 here.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Plexus.

Plexus will be holding an earnings conference call on Thursday, July 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Plexus Corp. (NASDAQ:PLXS) issued its earnings results on Wednesday, April, 27th. The technology company reported $0.95 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.12. The technology company had revenue of $888.70 million for the quarter, compared to the consensus estimate of $839.76 million. Plexus had a trailing twelve-month return on equity of 11.05% and a net margin of 3.31%. Plexus's quarterly revenue was up .9% compared to the same quarter last year. During the same period last year, the firm earned $1.49 earnings per share.
View Plexus' earnings history.

80 employees have rated Plexus CEO Todd Kelsey on Glassdoor.com. Todd Kelsey has an approval rating of 77% among Plexus' employees.

Some companies that are related to Plexus include Trimble (TRMB), Jabil (JBL), IPG Photonics (IPGP), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), Methode Electronics (MEI), TTM Technologies (TTMI), CTS (CTS), Benchmark Electronics (BHE), Park Aerospace (PKE), Neonode (NEON) and Key Tronic (KTCC).
View all of PLXS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Pfizer (PFE), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM), Teledyne FLIR (FLIR), First Solar (FSLR) and Gilead Sciences (GILD).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PLXS stock can currently be purchased for approximately $77.62.

Plexus (NASDAQ:PLXS) has a market capitalization of $2.15 billion and generates $3.37 billion in revenue each year. The technology company earns $138.91 million in net income (profit) each year or $3.88 on an earnings per share basis.

Plexus employs 19,200 workers across the globe.

Plexus was founded in 1979.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The official website for Plexus is www.plexus.com. The technology company can be reached via phone at (920) 969-6000, via email at heather.beresford@plexus.com, or via fax at 920-751-5395.